MedPath

The Incidence of Treatment-requiring Retinopathy of Prematurity in Greece

Completed
Conditions
Retinopathy of Prematurity
Registration Number
NCT05099588
Lead Sponsor
Aristotle University Of Thessaloniki
Brief Summary

A prospective observational study of the incidence of treatment-requiring ROP (TR-ROP), at a national level, in Greece.

Detailed Description

The purpose of this observational study is to prospectively collect data on ROP cases necessitating treatment at a national level. Each and every ROP screening unit in Greece (collaborating centers) report their new TR-ROP cases, their demographics and treatment characteristics, monthly, for a 12-month period. A reminder email is sent to avoid under-reporting due to neglect. Data are collected by the Responsible Party and will be analyzed together with national registry data on all preterm births in the same 12-month period.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
43
Inclusion Criteria
  • Preterm infants undergoing screening for ROP, who developed TR-ROP and were treated for ROP in one or two eyes.
Exclusion Criteria
  • None.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The incidence of treatment-requiring ROP (TR-ROP) in GreeceDuring the study period (1 year, prospectively)
Secondary Outcome Measures
NameTimeMethod
The rate of participants treated with laser photocoagulation versus anti-VEGF injectionDuring the study period (1 year, prospectively)
The mean gestational age and birth weight of infants treated for ROP in GreeceDuring the study period (1 year, prospectively)
The failure and recurrence rate of applied treatments for ROPDuring the follow-up period (6 months from treatment, prospectively)

Trial Locations

Locations (1)

Papageorgiou General Hospital

🇬🇷

Thessaloníki, Greece

© Copyright 2025. All Rights Reserved by MedPath